Delivery Order SPE2DB22D3401-SPE2DB26FT0JF
- Not listed
- The Defense Logistics Agency awarded a $3,127.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $5,327.53 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of September 12, 2025, represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework with DLA. This delivery order was competitively awarded with no set-aside designation, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order valued at $8,426.05 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This non-competitive, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's existing federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sumatriptan 6 mg/0.5ml auto-injectors with a ceiling value of $12,080.19. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $8,944.27 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitively awarded, firm fixed-price contract represents a single delivery order with an ultimate completion date of September 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,412.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of July 25, 2025, was awarded on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $2,914.29 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single procurement action under the company's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $2,652.22. This competitively awarded, firm fixed-price delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 8, 2025. The award represents a routine pharmaceutical supply transaction under a non-set-aside...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0JFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,187.56 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for completion by October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills pharmaceutical supply needs across the military and veteran healthcare systems. This delivery order is a child action under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/29/25 |